Enjoy Vibrant Health … Naturally

Novo Nordisk's diabetes drug succeeds in key trial

(Reuters) - Novo Nordisk A/S said on Wednesday its diabetes drug met the main goal of reducing glucose levels in patients in a key late-stage trial, setting the stage for it to become the new standard therapy for type 2 diabetes.